The COVID-19 pandemic has impacted health and well-being beyond the damage caused by the virus, with profound implications across the healthcare system. In nearly every US community, elective surgeries have been postponed and routine care has been delayed. Routine vaccinations have declined significantly across all populations, with demand plummeting as much as 95 percent for some vaccines.
To address these issues, NFID launched a national campaign to encourage all individuals to receive recommended vaccines that may have been delayed during the pandemic. The multimedia campaign engages national experts and leading public health organizations to reach populations most at risk of delaying vaccinations or experiencing complications from vaccine-preventable diseases.
- Vaccines are one of the most important and effective public health tools available to prevent a variety of diseases across the lifespan. During the COVID-19 pandemic, outbreaks of other infectious diseases will strain the capacity of US hospitals.
- Immunization protects entire communities. Individuals who are not able to get vaccinated due to underlying health conditions rely on community immunity to protect them. If communities are not up to date on recommended vaccines, vulnerable populations are left at greater risk of exposure to serious infectious diseases.
- Staying current on recommended vaccinations helps us to stay healthy and also protects those around us who are at greatest risk of serious complications from vaccine-preventable diseases.
The Keep Up The Rates campaign engages private sector and non-profit organizations around the critical goal of encouraging policymakers, consumers/patients, and healthcare professionals to take the necessary steps to maintain vaccination rates nationwide.
View the list of partner organizations who share the NFID vision of healthier lives through the effective prevention and treatment of infectious diseases, including flu
The NFID Keep Up The Rates campaign has been recognized as a 2021 Power of A Gold Award Winner by the American Society of Association Executives
This initiative is supported by GSK, Pfizer Inc., and Sanofi Pasteur. NFID policies restrict funders from controlling program content.
Reviewed January 2022